Inventiva (IVA) Other Non-Current Assets (2018 - 2025)
Inventiva's (IVA) quarterly Other Non-Current Assets came in at $1.4 million in Q4 2025, up 20.9% year-on-year from $1.1 million in Q4 2024, and down 99.89% quarter-over-quarter from $1.2 billion in Q2 2025.
Inventiva (IVA) Other Non-Current Assets (2018 - 2025) Analysis & Trends
Inventiva's Other Non-Current Assets history runs 8 years deep, the most recent figure standing at $1.4 million for Q4 2025.
- On a quarterly basis, Other Non-Current Assets rose 20.9% year-over-year to $1.4 million in Q4 2025; TTM through Dec 2025 was $1.4 million, a 20.9% increase from a year earlier, with the FY2025 full-year figure at $1.4 million, up 20.9% from the prior year.
- Other Non-Current Assets retreated to $1.4 million in Q4 2025 per IVA's latest filing, from $1.2 billion in the prior quarter.
- Across five years, Other Non-Current Assets topped out at $1.7 billion in Q2 2022 and bottomed at $1.1 million in Q4 2024.
- The 5-year median for Other Non-Current Assets is $3.3 million (2021), against an average of $269.2 million.
- Across the five-year window, Other Non-Current Assets plunged 99.36% in 2023 and soared 105014.01% in 2025, its largest moves.
- Year by year, Other Non-Current Assets stood at $2.8 million in 2021, then tumbled by 39.08% to $1.7 million in 2022, then soared by 538.57% to $10.9 million in 2023, then plunged by 89.7% to $1.1 million in 2024, then increased by 20.9% to $1.4 million in 2025.
- Per Business Quant, the three latest IVA Other Non-Current Assets figures stand at $1.4 million (Q4 2025), $1.2 billion (Q2 2025), and $1.1 million (Q4 2024).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Other Non-Current Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | 1.02 Mn |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 104.24 Mn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 1.26 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | 2.13 Bn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | 289.41 Mn |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | 124.00 Mn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | 14.48 Mn |
| 10 | Inventiva | 842.48 Mn | 842.48 Mn | - | 1.35 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 1.35 Mn |
| Jun 30, 2025 | 1.19 Bn |
| Dec 31, 2024 | 1.12 Mn |
| Jun 30, 2024 | 1.13 Mn |
| Dec 31, 2023 | 10.87 Mn |
| Jun 30, 2023 | 11.20 Mn |
| Dec 31, 2022 | 1.70 Mn |
| Jun 30, 2022 | 1.74 Bn |
| Dec 31, 2021 | 2.79 Mn |
| Jun 30, 2021 | 4.15 Mn |
| Mar 31, 2021 | 3.32 Mn |
| Dec 31, 2020 | 2.03 Mn |
| Jun 30, 2020 | 4.56 Mn |
| Dec 31, 2019 | 3.47 Mn |
| Dec 31, 2018 | 2.71 Mn |